These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 329987)

  • 1. Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).
    Dyke RW; Nelson RL
    Cancer Treat Rev; 1977 Jun; 4(2):135-42. PubMed ID: 329987
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
    Nelson RL
    Med Pediatr Oncol; 1982; 10(2):115-27. PubMed ID: 7070351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vindesine as a single agent in the treatment of advanced malignant melanoma.
    Retsas S; Newton KA; Westbury G
    Cancer Chemother Pharmacol; 1979; 2(4):257-60. PubMed ID: 455584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.
    Cersosimo RJ; Bromer R; Licciardello JT; Hong WK
    Pharmacotherapy; 1983; 3(5):259-74. PubMed ID: 6359081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
    Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
    Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer.
    Nelson RL; Dyke RW; Root MA
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():17-24. PubMed ID: 7438117
    [No Abstract]   [Full Text] [Related]  

  • 7. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.
    Evans BD; Smith IE; Shorthouse AJ; Millar JL
    Br J Cancer; 1982 Mar; 45(3):466-8. PubMed ID: 6280742
    [No Abstract]   [Full Text] [Related]  

  • 9. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

  • 10. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
    Smith IE; Coombes RC; Evans BD; Ford HT; Gazet JC; Gordon C; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():271-3. PubMed ID: 7032939
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of vincristine and vindesine on cell cycle kinetics in vitro.
    Hill BT; Whelan RD
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():5-15. PubMed ID: 6159973
    [No Abstract]   [Full Text] [Related]  

  • 12. Vindesine. A short review of preclinical and first clinical data.
    Dyke RW; Nelson RL; Brade WP
    Cancer Chemother Pharmacol; 1979; 2(4):229-32. PubMed ID: 455579
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of vindesine in advanced neoplastic disease.
    Stambaugh JE
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
    [No Abstract]   [Full Text] [Related]  

  • 14. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).
    Bhushana Rao KS; Collard MP; Trouet A
    Anticancer Res; 1985; 5(4):379-86. PubMed ID: 3898995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of vindesine in metastatic malignant melanoma.
    Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
    Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous infusion vindesine in solid tumors.
    Bodey GP; Yap HY; Yap BS; Valdivieso M
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():39-45. PubMed ID: 7438120
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of vincristine and vindesine in the treatment of inoperable non-small cell bronchial carcinoma.
    Jewkes J; Harper PG; Tobias JS; Geddes DM; Souhami RL; Spiro SG
    Cancer Treat Rep; 1983 Dec; 67(12):1119-21. PubMed ID: 6360349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of vindesine in patients with malignant melanoma.
    Camacho FJ; Young CW; Wittes RE
    Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
    [No Abstract]   [Full Text] [Related]  

  • 20. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.